INFANTS' MOTRIN CONCENTRATED DROPS OTC
Generic Name and Formulations:
Ibuprofen 50mg/1.25mL; berry-flavored susp; original or dye-free; alcohol-free.
McNeil Consumer Healthcare
Indications for INFANTS' MOTRIN CONCENTRATED DROPS:
Minor aches and pain. Fever.
Use appropriate formulation and give every 6–8 hours. <6months: not recommended. 12–17lbs: 50mg. 18–23lbs: 75mg. 24–35lbs: 100mg. 36–47lbs: 150mg. 48–59lbs: 200mg. 60–71lbs: 250mg. 72–95lbs: 300mg.
Aspirin allergy. Immediately before or after cardiac surgery.
Increased risk of severe stomach bleeding or persistent sore throat (do not use >2 days or children <3 years). History of GI disorders (eg, heartburn, bleeding ulcers). Increased risk of heart attack or failure, and stroke. Hypertension. Heart disease. Recent stroke. Liver cirrhosis. Renal disease. Asthma. Dehydration. Reevaluate if no relief within 24 hours of treatment; pain or fever persists or worsens >3 days. Pregnancy. Nursing mothers.
NSAID (propionic acid deriv.).
Avoid aspirin or other pain relievers. Increased risk of GI bleed with anticoagulants, corticosteroids, other OTC or Rx NSAID-containing products (eg, ibuprofen, naproxen, others), or prolonged use. Caution with diuretics.
GI upset/bleed, symptoms of heart problems or stroke (eg, trouble breathing, feel faint, slurred speech), redness, swelling, allergic reactions; discontinue if occur.
Susp—1oz, 4oz; Drops—½ oz, 1oz
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Emergency Physicians Offer Recommendations for Identifying and Managing Opioid Use Disorder
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness